Next-Generation 'Rocker' Bioreactor is Ideal for Suspension Cultures for Life Sciences Applications Up to Full GMP Production PORT WASHINGTON, N.Y.--(BUSINESS WIRE)-- Pall Corporation (NYSE:PLL ...

Pall Corporation, a leader in filtration, separation and purification, is pleased to introduce the mPath™ bioreactor control system to the biopharmaceutical market. The mPath benchtop bioreactor ...

The mPath benchtop bioreactor control system delivers accurate measurement and control of single-use process development-scale bioprocesses. It will support the Allegro™ XRS 25 bioreactor ...

The Freeline proprietary adeno-associated virus (AAV) manufacturing platform uses Pall’s iCELLis bioreactor system to produce AAV gene therapy vectors. The two companies will extend their partnership ...

Xcellerex recently introduced the XDR-10 benchtop bioreactor, expanding its product range from 10 L to 2,000 L for enhanced linear scalability. The new system ... program with Pall will result ...

New Brunswick Scientific, an Eppendorf Company (Edison, NJ, www.nbsc.com), and Pall Corporation ... as the new system will enable us to offer an even broader range of bioreactor technology ...

Pall is moving into proteomics, genomics, and diagnostic technologies, he says. The company's January acquisition of MicroReactor Technologies, a maker of high-throughput miniature bioreactor ...

Along with the RoosterBio hMSCs and media, the Pall solution offerings such as XRS 20 and Xpansion multiplate bioreactors, SoloHill microcarriers, and Allegro biocontainers enable our customers to ...

By adding the CelliGen bioprocess controller system, Pall is extending the range of its Allegro disposable bioreactor's upstream application capabilities to span process development through full ...

PORT WASHINGTON, N.Y.--(BUSINESS WIRE)--Pall Corporation (NYSE: PLL) announced today that its GeneDisc Rapid Microbiology system has been validated by the AOAC Research Institute for detection of ...